Jiangsu, China

Ran Wu

This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ran Wu. Retrieved from https://idiyas.com/inventor/ran-wu-54gmlrwg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ran Wu

Introduction

Ran Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative patent. His work reflects a commitment to advancing medical science and improving patient care.

Latest Patents

Ran Wu holds a patent for a "Multi-Receptor Agonist and Medical Use Thereof." This invention showcases his expertise in developing new therapeutic approaches that can potentially benefit a wide range of medical conditions. His patent portfolio includes 1 patent, highlighting his focused contributions to the industry.

Career Highlights

Throughout his career, Ran Wu has worked with prominent companies in the pharmaceutical sector. He has been associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. These experiences have allowed him to collaborate with leading professionals in the field and contribute to groundbreaking research and development.

Collaborations

Ran Wu has collaborated with talented individuals such as Fangzhou Wu and Lei Wang. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Ran Wu's innovative spirit and dedication to medical advancements are evident in his work and collaborations. His contributions to the pharmaceutical industry continue to pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…